Jason P. Lynch

1.5k citations

27 papers · 930 indexed · 1 hit paper · h-index 15

Co-authors: Simon Phipps Cammie F. Lesser Lisa Goers Vivian Zhang John W. Upham Rhiannon B. Werder Kirsten Spann Zhixuan Loh
Topics: Respiratory viral infections research (8 papers)IL-33, ST2, and ILC Pathways (8 papers)Asthma and respiratory diseases (5 papers)
Cited by: Immunology Physiology Immunology and Allergy
Journals: Proceedings of the National Academy of Sciences The Journal of Immunology American Journal of Respiratory and Critical Care Medicine
Partner nations: Australia United States United Kingdom

In The Last Decade

Jason P. Lynch

26 papers receiving 923 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Emerging strategies for engineering Escherichia coli Nissle 1917-based therapeutics

2022 116 citations Jason P. Lynch, Lisa Goers et al. Trends in Pharmacological Sciences profile →

Peers

Countries citing papers authored by Jason P. Lynch

Since Specialization

Citations

This map shows the geographic impact of Jason P. Lynch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jason P. Lynch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jason P. Lynch more than expected).

Fields of papers citing papers by Jason P. Lynch

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jason P. Lynch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jason P. Lynch. The network helps show where Jason P. Lynch may publish in the future.

Co-authorship network of co-authors of Jason P. Lynch

This figure shows the co-authorship network connecting the top 25 collaborators of Jason P. Lynch. A scholar is included among the top collaborators of Jason P. Lynch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jason P. Lynch. Jason P. Lynch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	In situ deposition of nanobodies by an engineered commensal microbe promotes survival in a mouse model of enterohemorrhagic E. coli 2024 ·PNAS Nexus ·(unknown),(unknown),Jason P. Lynch,(unknown),(unknown),(unknown),Luísa Lemos,(unknown),Marcia S. Osburne,John M. Leong,Cammie F. Lesser	4
2	PROT3EcT, engineered Escherichia coli for the targeted delivery of therapeutics 2023 ·Trends in Molecular Medicine ·(unknown),Jason P. Lynch,Cammie F. Lesser	5
3	Engineered Escherichia coli for the in situ secretion of therapeutic nanobodies in the gut 2023 ·Cell Host & Microbe ·Jason P. Lynch,(unknown),Analise Z. Reeves,Sena Bae,(unknown),(unknown),Jacqueline M. Tremblay,Florian I. Schmidt,Hidde L. Ploegh,Vikram Kansra,Jonathan N. Glickman,John M. Leong,Charles B. Shoemaker,Wendy S. Garrett,Cammie F. Lesser	64
4	Emerging strategies for engineering Escherichia coli Nissle 1917-based therapeuticsbreakdown → 2022 ·Trends in Pharmacological Sciences ·Jason P. Lynch,Lisa Goers,Cammie F. Lesser	116
5	Perinatal mental healthcare in Northern Ireland: challenges and opportunities 2021 ·Irish Journal of Psychological Medicine ·David Mongan,Jason P. Lynch,J. Anderson,Laura Robinson,Ciaran Mulholland	2
6	Respiratory Syncytial Virus Infection Promotes Necroptosis and HMGB1 Release by Airway Epithelial Cells 2020 ·American Journal of Respiratory and Critical Care Medicine ·Jennifer Simpson,Zhixuan Loh,Md Ashik Ullah,Jason P. Lynch,Rhiannon B. Werder,(unknown),Vivian Zhang,Yves Dondelinger,Mathieu J.M. Bertrand,Mark L. Everard,Christopher C. Blyth,Günter Härtel,Antoon J. van Oosterhout,Peter J. Gough,John Bertin,John W. Upham,Kirsten Spann,Simon Phipps	89
7	Long-lived regulatory T cells generated during severe bronchiolitis in infancy influence later progression to asthma 2020 ·Mucosal Immunology ·Jason P. Lynch,Rhiannon B. Werder,Bodie F. Curren,Md Al Amin Sikder,Md Ashik Ullah,Ismail Sebina,Ridwan Bin Rashid,Vivian Zhang,John W. Upham,Geoffrey R. Hill,Raymond J. Steptoe,Simon Phipps	14
8	HMGB1 amplifies ILC2-induced type-2 inflammation and airway smooth muscle remodelling 2020 ·PLoS Pathogens ·Zhixuan Loh,Jennifer Simpson,Md Ashik Ullah,Vivian Zhang,Wan Jun Gan,Jason P. Lynch,Rhiannon B. Werder,Md Al Amin Sikder,Katie Lane,Choon Boon Sim,Enzo R. Porrello,Stuart B. Mazzone,Peter D. Sly,Raymond J. Steptoe,Kirsten Spann,Maria B. Sukkar,John W. Upham,Simon Phipps	37
9	Chronic IL-33 expression predisposes to viral-induced exacerbations of asthma by increasing type-2 inflammation and dampening antiviral immunity 2018 ·Journal of Allergy and Clinical Immunology ·Rhiannon B. Werder,Vivian Zhang,Jason P. Lynch,(unknown),John W. Upham,Kirsten Spann,Simon Phipps	2
10	Chronic IL-33 expression predisposes to virus-induced asthma exacerbations by increasing type 2 inflammation and dampening antiviral immunity 2017 ·Journal of Allergy and Clinical Immunology ·Rhiannon B. Werder,Vivian Zhang,Jason P. Lynch,(unknown),John W. Upham,Kirsten Spann,Simon Phipps	56
11	Critical Role of Plasmacytoid Dendritic Cells in Regulating Gene Expression and Innate Immune Responses to Human Rhinovirus-16 2017 ·Frontiers in Immunology ·(unknown),Niamh Troy,Denise Anderson,Olga M. Pena,Jason P. Lynch,Simon Phipps,Anthony Bosco,John W. Upham	11
12	The Absence of Interferon-β Promotor Stimulator-1 (IPS-1) Predisposes to Bronchiolitis and Asthma-like Pathology in Response to Pneumoviral Infection in Mice 2017 ·Scientific Reports ·Jennifer Simpson,Jason P. Lynch,Zhixuan Loh,Vivian Zhang,Rhiannon B. Werder,Kirsten Spann,Simon Phipps	12
13	The Influence of the Microbiome on Early-Life Severe Viral Lower Respiratory Infections and Asthma—Food for Thought? 2017 ·Frontiers in Immunology ·Jason P. Lynch,Md Al Amin Sikder,Bodie F. Curren,Rhiannon B. Werder,Jennifer Simpson,Páraic Ó Cuív,Paul G. Dennis,Mark L. Everard,Simon Phipps	36
14	Aeroallergen-induced IL-33 predisposes to respiratory virus–induced asthma by dampening antiviral immunity 2016 ·Journal of Allergy and Clinical Immunology ·Jason P. Lynch,Rhiannon B. Werder,Jennifer Simpson,Zhixuan Loh,Vivian Zhang,Ashraful Haque,Kirsten Spann,Peter D. Sly,Stuart B. Mazzone,John W. Upham,Simon Phipps	72
15	Immunomodulation of Airway Epithelium Cell Activation by Mesenchymal Stromal Cells Ameliorates House Dust Mite–Induced Airway Inflammation in Mice 2015 ·American Journal of Respiratory Cell and Molecular Biology ·(unknown),(unknown),Md Ashik Ullah,Jason P. Lynch,Vivian Zhang,Kerry Atkinson,Peter D. Sly,Simon Phipps	26
16	IRF-3, IRF-7, and IPS-1 Promote Host Defense against Acute Human Metapneumovirus Infection in Neonatal Mice 2014 ·American Journal Of Pathology ·Kirsten Spann,Zhixuan Loh,Jason P. Lynch,Md Ashik Ullah,Vivian Zhang,Engin Baturcam,Rhiannon B. Werder,(unknown),Penny A. Rudd,Yueh–Ming Loo,Andreas Suhrbier,Michael Gale,John W. Upham,Simon Phipps	25
17	TLR7 gene deficiency and early-life pneumovirus infection interact to predispose toward the development of asthma-like pathology in mice 2013 ·European Respiratory Journal ·Gerard E. Kaiko,Zhixuan Loh,Kirsten Spann,Jason P. Lynch,(unknown),Sophia Davidson,Paul S. Foster,Simon Phipps	3
18	Toll-like receptor 7 gene deficiency and early-life Pneumovirus infection interact to predispose toward the development of asthma-like pathology in mice 2013 ·Journal of Allergy and Clinical Immunology ·Gerard E. Kaiko,Zhixuan Loh,Kirsten Spann,Jason P. Lynch,(unknown),(unknown),Sophia Davidson,Satoshi Uematsu,Shizuo Akira,John D. Hayball,Kerrilyn R. Diener,Katherine J. Baines,Jodie L. Simpson,Paul S. Foster,Simon Phipps	51
19	The receptor for complement component C3a mediates protection from intestinal ischemia-reperfusion injuries by inhibiting neutrophil mobilization 2013 ·Proceedings of the National Academy of Sciences ·Mike C. L. Wu,Faith H. Brennan,Jason P. Lynch,Susanna Mantovani,Simon Phipps,Rick A. Wetsel,Marc J. Ruitenberg,Stephen M. Taylor,Trent M. Woodruff	128
20	The plasmacytoid dendritic cell: at the cross-roads in asthma 2013 ·European Respiratory Journal ·Jason P. Lynch,Stuart B. Mazzone,(unknown),(unknown),Zhixuan Loh,Antonia L. Pritchard,John W. Upham,Simon Phipps	47

About Jason P. Lynch

Jason P. Lynch is a scholar working on Endocrinology, Immunology and Emergency Medical Services, having authored 27 papers that have together received 930 indexed citations. Recurring topics across this work include Respiratory viral infections research (8 papers), IL-33, ST2, and ILC Pathways (8 papers) and Asthma and respiratory diseases (5 papers). The work is most often cited by research in Immunology (427 citations), Physiology (237 citations) and Immunology and Allergy (50 citations). Jason P. Lynch has collaborated with scholars based in Australia, United States and United Kingdom. Frequent co-authors include Simon Phipps, Cammie F. Lesser, Lisa Goers, Vivian Zhang, John W. Upham, Rhiannon B. Werder, Kirsten Spann, Zhixuan Loh, Jennifer Simpson and Stuart B. Mazzone. Their work appears in journals such as Proceedings of the National Academy of Sciences, The Journal of Immunology and American Journal of Respiratory and Critical Care Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact